Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo.

Ghosh S, Sharma G, Travers J, Kumar S, Choi J, Jun HT, Kehry M, Ramaswamy S, Jenkins D.

Mol Cancer Ther. 2019 Mar;18(3):632-641. doi: 10.1158/1535-7163.MCT-18-0836. Epub 2018 Dec 26.

PMID:
30587557
2.

Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy.

Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, Shen M, Zhang L, Tupitsyn N, Pantel K, King C, Sun J, Moriguchi J, Jun HT, Coxon A, Lee B, Kang Y.

Cancer Cell. 2017 Dec 11;32(6):731-747.e6. doi: 10.1016/j.ccell.2017.11.002.

3.

Subsequent Vertebral Fractures Post Cement Augmentation of the Thoracolumbar Spine: Does it Correlate With Level-specific Bone Mineral Density Scores?

Hey HW, Tan JH, Tan CS, Tan HM, Lau PH, Hee HT.

Spine (Phila Pa 1976). 2015 Dec;40(24):1903-9. doi: 10.1097/BRS.0000000000001066. Erratum in: Spine (Phila Pa 1976). 2016 Feb;41(4):368. Hwee Weng, Dennis Hey [corrected to Hey, Hwee Weng Dennis]; Jun, Hao Tan [corrected to Tan, Jun Hao]; Chuen, Seng Tan [corrected to Tan, Chuen Seng]; Ming, Bryan Tan Hsi [corrected to Tan, Hsi Ming Bryan]; Huh, Bernard Lau Puang [corrected to Lau, Puang Hu.

PMID:
26208228
4.

Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.

Buchanan JL, Newcomb JR, Carney DP, Chaffee SC, Chai L, Cupples R, Epstein LF, Gallant P, Gu Y, Harmange JC, Hodge K, Houk BE, Huang X, Jona J, Joseph S, Jun HT, Kumar R, Li C, Lu J, Menges T, Morrison MJ, Novak PM, van der Plas S, Radinsky R, Rose PE, Sawant S, Sun JR, Surapaneni S, Turci SM, Xu K, Yanez E, Zhao H, Zhu X.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2394-9. doi: 10.1016/j.bmcl.2011.02.075. Epub 2011 Feb 23.

PMID:
21414779
5.

Supplemental Content

Support Center